Live feed08:00:00·559dPRReleasevia QuantisnowKrystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic LevelsByQuantisnow·Wall Street's wire, on your screen.KRYS· Krystal Biotech Inc.Health Care
